Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease

Brain Research

Volumn 1286, Issue , 2009, Pages 25-31

  Cheng, Baohua ^a,c   Yang, Xinxin ^a,b   An, Liangxiang ^b   Gao, Bo ^a   Liu, Xia ^a   Liu, Shuwei ^c  

^a JINING MEDICAL UNIVERSITY   (China)

^b Rizhao People's Hospital   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

6 hydroxydopamine; Glutathione; Ketogenic diet; Ketone body; Parkinson's disease

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLUTATHIONE; HOMOVANILLIC ACID; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; KETOGENIC DIET; LIPID DIET; MALE; NEUROPROTECTION; NEUROTOXICITY; NISSL STAINING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ADRENERGIC AGENTS; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; GLUTATHIONE; HOMOVANILLIC ACID; IMMUNOHISTOCHEMISTRY; KETOGENIC DIET; NERVE DEGENERATION; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

RATTUS;

EID: 67849116702     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.060     Document Type: Article

References (27)

1. Chen H.Q., et al. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation. Neurosci. Lett. 417 (2007) 112-117
2. Chinta S.J., and Andersen J.K. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Radic. Biol. Med. 41 (2006) 1442-1448
3. Faria M.H., et al. Ketone bodies metabolism during ischemic and reperfusion brain injuries following bilateral occlusion of common carotid arteries in rats. Acta Cir. Bras. 22 (2007) 125-129
4. Finn P.F., and Dice J.F. Ketone bodies stimulate chaperone-mediated autophagy. J. Biol. Chem. 280 (2005) 25864-25870
5. Greenamyre J.T., and Hastings T.G. Biomedicine. Parkinson's-divergent causes, convergent mechanisms. Science. 304 (2004) 1120-1122
6. Henze C., et al. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. Brain Res. 1052 (2005) 97-104
7. Iida M., et al. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 838 (1999) 51-59
8. Imamura K., et al. d-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J. Neurosci. Res. 84 (2006) 1376-1384
9. Jarrett S.G., et al. The ketogenic diet increases mitochondrial glutathione levels. J. Neurochem. 106 (2008) 1044-1051
10. Koustova E., et al. Ketone and pyruvate Ringer's solutions decrease pulmonary apoptosis in a rat model of severe hemorrhagic shock and resuscitation. Surgery 134 (2003) 267-274
11. Kulich S.M., et al. 6-Hydroxydopamine induces mitochondrial ERK activation. Free Radic. Biol. Med. 43 (2007) 372-383
12. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 15 (1999) 412-426
13. Leret M.L., et al. Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum. Toxicology 170 (2002) 165-171
14. Maguire-Zeiss K.A., et al. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?. Brain Res. Mol. Brain Res. 134 (2005) 18-23
15. Noh H.S., et al. Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3. J. Neurosci. Res. 84 (2006) 1829-1836
16. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, Sydney
17. Pinnen F., et al. Synthesis and study of l-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties. J. Med. Chem. 50 (2007) 2506-2515
18. Qu D., et al. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55 (2007) 37-52
19. Seyfried T.N., et al. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br. J. Cancer 89 (2003) 1375-1382
20. Shimizu E., et al. Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells. Neuropharmacology 43 (2002) 434-443
21. Sian J., et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36 (1994) 348-355
22. Smith S.L., et al. KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. CNS Drug Rev. 11 (2005) 113-140
23. Sullivan P.G., et al. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55 (2004) 576-580
24. Tanaka K., et al. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. Neurosci. Lett. 321 (2002) 45-48
25. Tieu K., et al. d-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 112 (2003) 892-901
26. Vanitallie T.B., et al. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 64 (2005) 728-730
27. Zhou C., et al. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. N. Y. Acad. Sci. 1147 (2008) 93-104